Final overall survival in JO22903, a phase II, open-label study of first-line erlotinib for Japanese patients with EGFR mutation-positive non-small-cell lung cancer
2016 ◽
Vol 22
(1)
◽
pp. 70-78
◽
Noboru Yamamoto
◽
Koichi Goto
◽
Makoto Nishio
◽
Kenichi Chikamori
◽
Toyoaki Hida
◽
...
2016 ◽
Vol 22
(1)
◽
pp. 79-79
◽
Noboru Yamamoto
◽
Koichi Goto
◽
Makoto Nishio
◽
Kenichi Chikamori
◽
Toyoaki Hida
◽
...
2014 ◽
Vol 121
(6)
◽
pp. 883-892
◽
Robert C. Doebele
◽
David Spigel
◽
Mustapha Tehfe
◽
Sachdev Thomas
◽
Martin Reck
◽
...
2021 ◽
Vol 32
◽
pp. S1456
B. Halmos
◽
P. Cobb
◽
M.L. Johnson
◽
L. Jain
◽
S.J. Kim
◽
...
2013 ◽
Vol 82
(1)
◽
pp. 109-114
◽
Koichi Goto
◽
Makoto Nishio
◽
Noboru Yamamoto
◽
Kenichi Chikamori
◽
Toyoaki Hida
◽
...
2017 ◽
Vol 28
◽
pp. ii42-ii43
S. Thomas
◽
R.C. Doebele
◽
D. Spigel
◽
M. Tehfe
◽
M. Reck
◽
...
2017 ◽
Vol 28
◽
pp. v542
◽
I. Okamoto
◽
H. Udagawa
◽
S. Kanda
◽
T.H. Han
◽
I. Lakatos
◽
...
2014 ◽
Vol 9
(10)
◽
pp. 1532-1539
◽
D. Ross Camidge
◽
Eamon M. Berge
◽
Robert C. Doebele
◽
Marc S. Ballas
◽
Thierry Jahan
◽
...
2017 ◽
Vol Volume 8
◽
pp. 217-229
Wolfgang Schuette
◽
Claus-Peter Schneider
◽
Walburga Engel-Riedel
◽
Christian Schumann
◽
Martin Kohlhaeufl
◽
...
2021 ◽
Vol 16
(1)
◽
pp. S27-S28
M.-J. Ahn
◽
F. Barlesi
◽
E. Felip
◽
E. Garon
◽
C.M. Martin
◽
...
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7588-7588
◽
D. R. Camidge
◽
M. S. Ballas
◽
S. Dubey
◽
M. Haigentz
◽
P. J. Rosen
◽
...
Close
Export Citation Format
Close
Share Document
Close